Skip to main content

and
  1. No Access

    Article

    Improvement of spontaneous speech in early stage Alzheimer’s disease with rivastigmine

    Placebo-controlled trials have shown that rivastigmine can delay cognitive deterioration in patients with mild to moderate Alzheimer’s disease (AD). Benefits on cognitive functioning, as measured with the ADAS...

    E. G. Visch-Brink, W. Van Rhee-Temme in JNHA - The Journal of Nutrition, Health an… (2009)